Control samples included BL samples incubated with BSA only (without Tat antibody) (Figure 1A), as well as an HIV negative DLBCL sample probed using an antibody against Tat, to show that Tat was specific to tumors from HIV infected patients only (Figures 1B,D). The gene discussed is TAT; the disease is diffuse large B-cell lymphoma.